NEW PHARMACEUTICAL ANTI-COUNTERFEITING SYSTEMS: A COMPARATIVE ASSESSMENT
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: MENDES, Bruno (School of Sciences and Health Technologies of University Lusófona, Quality & Health Strategy, Lisboa, Portugal)
- Co-author(s): Alexandre Campos
The pharmaceutical counterfeiting has a direct and indirect cost of €9,5 – 116 billions, taking near 30% of market share in developing countries. This growth is nowadays correlated with the non-usage of anti-counterfeiting systems (ACS) and with outdated legislation. This issue takes a larger proportion derived from the object of counterfeiting -.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.